E1	Condition:T1 Name:T2
E3	Observation:T3 Name:T4 Duration:E10
E6	Condition:T6 Name:T7
E7	Eq-Comparison:T19 Operator:T11 Value:T14 Value2:T15 Temporal-Unit:T9
E8	Eq-Comparison:T20 Operator:T12 Value:T17 Value2:T18 Unit:T35 Per:T36
E2	Drug:T21 Name:T22
E4	Drug:T23 Name:T24
E5	Or:T25 Arg:E2 Arg2:E4
E9	Negation:T26 Negates:E4
E10	Eq-Comparison:T27 Operator:T28 Value:T13 Temporal-Unit:T8
E11	Drug:T29 Name:T30
E12	Drug:T31 Name:T32 Temporality:E7 Duration:E13 Temporality2:E8
E13	Eq-Comparison:T33 Operator:T34 Value:T16 Temporal-Unit:T10
E14	Drug:T37 Name:T38
E15	Study:T39
E16	Temporal-Connection:T40 Arg:E14 Arg2:E15
E18	Condition:T41 Name:T5
E17	Negation:T43 Negates:E1
E19	Condition:T44 Name:T45
E20	Observation:T46 Name:T47
E21	Drug:T48 Name:T49
E22	Drug:T50 Name:T51
E23	Or:T52 Arg:E21 Arg2:E22
E24	Modifier:T53 Modifies:T7
E25	Modifier:T54 Modifies:T7
E26	Or:T55 Arg:E25 Arg2:E24
T1	Condition 538 525	cardiovascular disease
T2	Condition-Name 538 525	cardiovascular disease
T3	Observation 149 147	strength training
T4	Observation-Name 149 147	strength training
T6	Condition 694 675	disease
T7	Condition-Name 694 675	disease
T8	Eq-Temporal-Unit 171 168	years
T9	Eq-Temporal-Unit 320 313	weeks
T10	Eq-Temporal-Unit 342 334	years
T11	Eq-Operator 310 304	to
T12	Eq-Operator 352 342	-
T13	Eq-Value 165 162	2
T14	Eq-Value 307 301	8
T15	Eq-Value 314 307	12
T16	Eq-Value 336 328	2
T17	Eq-Value 350 341	2
T18	Eq-Value 355 343	4
T19	Eq-Comparison 320 313	8 to 12 weeks
T20	Eq-Comparison 371 359	2-4 cycles per year
T21	Drug 55 53	Anabolic androgenic steroids
T22	Drug-Name 55 53	Anabolic androgenic steroids
T23	Drug 94 92	Anabolic androgenic steroids
T24	Drug-Name 94 92	Anabolic androgenic steroids
T25	Or 65 63	and
T26	Negation 103 101	nonusers
T27	Eq-Comparison 171 168	at least 2 years
T28	Eq-Operator 162 160	at least
T29	Drug 206 203	Anabolic androgenic steroids
T30	Drug-Name 206 203	Anabolic androgenic steroids
T31	Drug 272 267	anabolic androgenic steroids
T32	Drug-Name 272 267	anabolic androgenic steroids
T33	Eq-Comparison 342 334	at least 2 years
T34	Eq-Operator 333 326	at least
T35	Eq-Unit 362 350	cycles
T36	Eq-Temporal-Unit 371 359	year
T37	Drug 410 398	anabolic androgenic steroids
T38	Drug-Name 410 398	anabolic androgenic steroids
T39	Study 461 449	study
T40	Temporal-Connection 448 436	over the course
T41	Condition 503 490	sedentary
T5	Condition-Name 503 490	sedentary
T42	Life-Stage-And-Gender 507 494	men
T43	Negation 515 502	without
T44	Condition 576 559	Smoking
T45	Condition-Name 576 559	Smoking
T46	Observation 602 585	Alcohol consumption
T47	Observation-Name 602 585	Alcohol consumption
T48	Drug 625 608	diuretics
T49	Drug-Name 625 608	diuretics
T50	Drug 663 644	antihypertensive medications
T51	Drug-Name 663 644	antihypertensive medications
T52	Or 634 615	and/or
T53	Modifier 686 667	kidney
T54	Modifier 675 656	Liver
T55	Or 679 660	and
A1	Eq-Temporal-Unit-Value T8 year
A2	Eq-Temporal-Unit-Value T9 week
A3	Eq-Temporal-Unit-Value T10 year
A4	Eq-Operator-Value T11 BETWEEN
A5	Eq-Operator-Value T12 BETWEEN
A6	Observation-Type-Value T4 social-habit
A7	Eq-Operator-Value T28 GTEQ
A8	Eq-Operator-Value T34 GTEQ
A9	Eq-Temporal-Unit-Value T36 year
A10	Temporal-Connection-Type-Value E16 during
A11	Life-Stage-And-Gender-Type T42 male
A12	Observation-Type-Value T47 social-habit
R1	If-Then Arg1:E11 Arg2:E12